This message was sent to ##Email##
|
|
|
|
|
|
Advertisement
|
|
|
Managed Care
The U.S. Preventive Services Task Force has released a final recommendation statement on screening for skin cancer. The Task Force found insufficient evidence to recommend for or against using visual examinations by clinicians to screen adults for skin cancer. The statement was published online in the Journal of the American Medical Association.
READ MORE
Oncology Nurse Advisor
A very large retrospective study of patients with stage II colon cancer found adjuvant therapy improves survival, regardless of treatment regimen, patient age or high-risk pathologic features. The role of adjuvant, or postoperative, therapy in early-stage colon cancer, even for high-risk cancers, has been questioned. Although adjuvant chemotherapy is known to help treat advanced colon cancer, current clinical guidelines recommend discussing this treatment option only with patients whose stage II cancer is considered high-risk and likely to return after surgery.
READ MORE
|
Promoted by
|
|
|
|
 |
PRWeb
Millions of Americans may have heard on the news that a recently released study, "Increasing incidence of metastatic prostate cancer in the United States (2004–2013)," which was e-published in the journal Prostate Cancer and Prostatic Diseases on July 19, 2016, shows metastatic prostate cancer was increasing dramatically in the United States. However, in response to this article, researchers from the North American Association of Central Cancer Registries analyzed data collected by cancer registries across the United States and found that rates of metastatic prostate cancer rates are stable.
READ MORE
Medscape
The U.S. population is aging, with the number of individuals aged 75 years and older projected to triple by mid-century. Although this change will result in a substantial increase in the number of older adults with breast cancer who are suitable for new therapeutic options, this population continues to remain underrepresented in clinical trials.
READ MORE
| |
PRODUCT SHOWCASE | Advertisement
|
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text.
|
|
ACS
The National Cancer Database (NCBD) Participant User File (PUF) application is accepting applications for site-specific files, which include cases diagnosed between 2004 and 2014. The application period remains open through Aug. 25.
The NCDB PUF is a Health Insurance Portability and Accountability Act-compliant data file containing cases submitted to the Commission on Cancer's (CoC) NCDB and complies with the terms of the Business Associate Agreement between the American College of Surgeons and cancer programs accredited by the CoC (i.e., no patients or facilities can be identified). The PUF is designed to provide investigators at CoC-accredited cancer programs with a data resource they can use to review and advance the quality of care delivered to cancer patients through analyses of cases reported to the NCDB. Use of the PUF is not required to meet any CoC standards, but it is an opportunity provided as a benefit of accreditation.
Prospective applicants can find more information about the application process and data items available on the PUF web page.
Additional questions regarding the NCDB PUFs may be directed to the NCDB.
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
Medical News Today
According to the American Cancer Society, around 53,070 people will be diagnosed with pancreatic cancer in the Unites States in 2016, and around 41,780 people will die of the disease. Pancreatic cancer accounts for about 3 percent of all cancers in the U.S. and about 7 percent of cancer deaths.
Pancreatic cancer is caused by the abnormal, uncontrolled growth of cells in the pancreas.
READ MORE
NPR
Healthy young women can be forgiven for being confused about how often they're supposed to be getting in to see their primary care doctor.
After all, annual checkups in general have come under scrutiny. Doctors who have reviewed the data say there is little scientific evidence to support routine pelvic exams or clinical breast exams in women who have no symptoms. Cervical cancer screening is now recommended only every three years. Even a routine blood test to measure cholesterol levels isn't recommended for women under 45.
So, is it best to skip that annual wellness visit with a gynecologist or other family practitioner?
READ MORE
The AJCC announces five disease site webinars that are scheduled for summer and early fall this year. The webinars, offered at no cost, will provide highlights of the five most common site chapters for AJCC 7th edition staging and include: Melanoma, Lung, Breast, Colorectum and Prostate. There will be pre- and post-education quizzes to serve as a self-assessment for the information learned. The webinars will provide information on the uniqueness, differences, exceptions or special concerns for the disease sites.
Each lecture will contain the following topics:
Overview and Learning Objectives
Anatomy Affecting Stage
Classification Issues
Assigning T, N, M, Stage Group
Information and Questions on AJCC Staging and Summary
Melanoma is now available as a recording on the AJCC website. The second webinar (Lung) will be held Aug. 10. The third webinar (Breast) will be held on Aug. 31. The webinars will be recorded for anyone who is not able to attend the live session. Register now.
You can visit the AJCC website to learn more about the Disease Site webinars and stay informed.
READ MORE
Medscape
The earliest evidence of both a malignant and a benign tumor has been found in human fossils from two separate caves in South Africa. The fossils date back almost 2 million years, showing that cancer is not a disease caused by our modern lifestyles, as some have suggested.
READ MORE
October is Breast Cancer Awareness Month. The National Accreditation Program for Breast Centers (NAPBC) and the Commission on Cancer (CoC) encourage you to promote Breast Cancer Awareness Month and use it as an opportunity to display and publicize your program's accreditation status with the CoC and NAPBC.
The NAPBC and the CoC have created a poster to use within your program and community.
How to access the poster
Programs that are accredited solely by the NAPBC, use the Marketing Resources website link that was provided in your performance report email notification.
Programs that are accredited solely by the CoC or both the CoC and NAPBC, go to CoC Datalinks and click on Marketing Resources.
Please let us know about your celebration by sending photos and event information to Susan Rubin, business development manager, ACS Cancer Programs.
READ MORE
|
|
Advertisement
 |
|
For the past 22 years, EduCare's mission has been to support Healthcare Professionals in educating breast cancer patients. We strive to offer products that are patient-friendly and up-to-date. Patient education increases compliance, reduces time constraints and promotes a partnership between patient and healthcare providers.
|
|
|
|
|
Advertisement
 |
|
Specialty Practice Management is a complete front- and back-office solution that offers a rapid return on your investment and improved satisfaction among your staff. Practices with 10 or fewer providers turn to this comprehensive solution to manage self-pay accounts and eliminate common mistakes.
|
|
|
|
ACS
Accreditation 101: Learning the Basics of CoC Accreditation and Standards will be held Sept. 9 in Chicago. This one-day program, taught by CoC surveyors and staff, provides an overview of the CoC accreditation standards and answers your questions about the standards and the survey process. This is the last time this program will be held in 2016.
ACS
The scientific program, online registration, travel and housing reservation links, and previews of other planned events for the American College of Surgeons (ACS) Clinical Congress 2016, Oct. 16–20 in Washington, D.C., are now available online. The Walter E. Washington Convention Center will be the host site for the scientific sessions, courses, and scientific posters and technical exhibits; the Marriott Marquis Washington, D.C., will serve as the headquarters hotel for the meeting. Register by Monday, Aug. 22 to take advantage of early-bird pricing.
READ MORE
FierceBiotech
Flagship's recently merged upstart Evelo Biosciences is partnering with the Mayo Clinic in an attempt to use bacteria to help stimulate an immune response to cancer.
This exclusive collaboration, financial details of which were not disclosed (although Mayo will receive some money from the biotech), will see the two work on immuno-microbiome-based therapies against a number of tumors.
READ MORE
CoC
The Commission on Cancer (CoC) announces an updated web-based contact form, which allows you to select the subject based on your topic. Your questions will then be sent the appropriate staff person for response. In the near future, the CoC will discontinue the SAR@facs.org email address.
Medical Xpress
The formation of large numbers of polyps in the colon has a high probability of developing into colon cancer if left untreated. The large-scale appearance of polyps is often due to a hereditary cause; in this case the disease can occur in multiple family members. Under the leadership of human geneticists of the University Hospital Bonn, a team of researchers discovered genetic changes in the MSH3 gene in patients and identified a new rare form of hereditary colon cancer. The results have now been published in the American Journal of Human Genetics.
READ MORE
For additional information, please complete the mailing list request form.
|
|
|
Advertisement
Advertisement
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
